scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Interaction Propensity (Tier 1)

Download spatial tables

Interaction Propensity (Tier 1)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B7,9 Lung Primary cancer 3,924 Other -> Other Enriched 3.08 9.90e-3
NSCLC_38242124__IMC__175_B8,1 Lung Primary cancer 2,457 Tumor/Malignant -> Tumor/Malignant Enriched 4.90 1.06e-2
NSCLC_38242124__IMC__175_B8,10 Lung Primary cancer 2,512 Stromal -> Stromal Enriched 3.69 1.22e-2
NSCLC_38242124__IMC__175_B8,11 Lung Primary cancer 1,996 Tumor/Malignant -> Tumor/Malignant Enriched 4.47 1.22e-2
NSCLC_38242124__IMC__175_B8,12 Lung Primary cancer 4,012 Tumor/Malignant -> Tumor/Malignant Enriched 5.62 9.90e-3
NSCLC_38242124__IMC__175_B8,13 Lung Primary cancer 2,892 Stromal -> Stromal Enriched 4.26 1.13e-2
NSCLC_38242124__IMC__175_B8,14 Lung Primary cancer 2,759 Tumor/Malignant -> Tumor/Malignant Enriched 4.99 1.22e-2
NSCLC_38242124__IMC__175_B8,15 Lung Primary cancer 4,072 Tumor/Malignant -> Tumor/Malignant Enriched 5.20 1.44e-2
NSCLC_38242124__IMC__175_B8,16 Lung Primary cancer 3,106 Tumor/Malignant -> Tumor/Malignant Enriched 4.96 1.32e-2
NSCLC_38242124__IMC__175_B8,17 Lung Primary cancer 3,192 Immune -> Immune Enriched 4.72 9.90e-3
NSCLC_38242124__IMC__175_B8,2 Lung Primary cancer 3,741 Tumor/Malignant -> Tumor/Malignant Enriched 4.61 9.90e-3
NSCLC_38242124__IMC__175_B8,3 Lung Primary cancer 891 Tumor/Malignant -> Tumor/Malignant Enriched 3.07 2.64e-2
NSCLC_38242124__IMC__175_B8,4 Lung Primary cancer 2,257 Tumor/Malignant -> Tumor/Malignant Enriched 4.68 1.06e-2
NSCLC_38242124__IMC__175_B8,5 Lung Primary cancer 5,087 Tumor/Malignant -> Tumor/Malignant Enriched 5.37 1.06e-2
NSCLC_38242124__IMC__175_B8,6 Lung Primary cancer 4,367 Tumor/Malignant -> Tumor/Malignant Enriched 4.38 1.22e-2
NSCLC_38242124__IMC__175_B8,7 Lung Primary cancer 2,512 Tumor/Malignant -> Tumor/Malignant Enriched 4.24 1.06e-2
NSCLC_38242124__IMC__175_B8,8 Lung Primary cancer 3,952 Tumor/Malignant -> Tumor/Malignant Enriched 4.92 1.32e-2
NSCLC_38242124__IMC__175_B8,9 Lung Primary cancer 4,684 Tumor/Malignant -> Tumor/Malignant Enriched 4.51 1.58e-2
NSCLC_38242124__IMC__175_C1,1 Lung Primary cancer 5,194 Tumor/Malignant -> Tumor/Malignant Enriched 5.21 9.90e-3
NSCLC_38242124__IMC__175_C1,10 Lung Primary cancer 4,235 Tumor/Malignant -> Tumor/Malignant Enriched 5.37 1.06e-2
NSCLC_38242124__IMC__175_C1,11 Lung Primary cancer 3,589 Tumor/Malignant -> Tumor/Malignant Enriched 4.26 1.06e-2
NSCLC_38242124__IMC__175_C1,12 Lung Primary cancer 2,616 Tumor/Malignant -> Tumor/Malignant Enriched 5.46 1.32e-2
NSCLC_38242124__IMC__175_C1,13 Lung Primary cancer 2,103 Tumor/Malignant -> Tumor/Malignant Enriched 4.04 1.06e-2
NSCLC_38242124__IMC__175_C1,14 Lung Primary cancer 3,235 Tumor/Malignant -> Tumor/Malignant Enriched 5.30 1.13e-2
NSCLC_38242124__IMC__175_C1,15 Lung Primary cancer 2,953 Immune -> Immune Enriched 4.50 1.13e-2
NSCLC_38242124__IMC__175_C1,16 Lung Primary cancer 6,299 Immune -> Immune Enriched 5.63 1.98e-2
NSCLC_38242124__IMC__175_C1,2 Lung Primary cancer 2,108 Tumor/Malignant -> Tumor/Malignant Enriched 3.12 1.44e-2
NSCLC_38242124__IMC__175_C1,3 Lung Primary cancer 3,373 Tumor/Malignant -> Tumor/Malignant Enriched 4.24 1.06e-2
NSCLC_38242124__IMC__175_C1,4 Lung Primary cancer 3,548 Immune -> Immune Enriched 3.88 1.32e-2
NSCLC_38242124__IMC__175_C1,5 Lung Primary cancer 1,652 Tumor/Malignant -> Tumor/Malignant Enriched 4.78 1.06e-2
NSCLC_38242124__IMC__175_C1,7 Lung Primary cancer 4,101 Tumor/Malignant -> Tumor/Malignant Enriched 5.20 9.90e-3
NSCLC_38242124__IMC__175_C1,8 Lung Primary cancer 3,113 Immune -> Immune Enriched 3.72 1.13e-2
NSCLC_38242124__IMC__175_C1,9 Lung Primary cancer 3,009 Tumor/Malignant -> Tumor/Malignant Enriched 5.21 1.13e-2
NSCLC_38242124__IMC__175_C2,1 Lung Primary cancer 4,243 Tumor/Malignant -> Tumor/Malignant Enriched 4.73 1.13e-2
NSCLC_38242124__IMC__175_C2,10 Lung Primary cancer 3,797 Tumor/Malignant -> Tumor/Malignant Enriched 5.65 1.06e-2
NSCLC_38242124__IMC__175_C2,11 Lung Primary cancer 2,770 Tumor/Malignant -> Tumor/Malignant Enriched 4.10 1.13e-2
NSCLC_38242124__IMC__175_C2,12 Lung Primary cancer 3,309 Tumor/Malignant -> Tumor/Malignant Enriched 5.60 1.32e-2
NSCLC_38242124__IMC__175_C2,13 Lung Primary cancer 4,144 Immune -> Immune Enriched 4.00 1.22e-2
NSCLC_38242124__IMC__175_C2,14 Lung Primary cancer 2,934 Tumor/Malignant -> Tumor/Malignant Enriched 5.35 1.13e-2
NSCLC_38242124__IMC__175_C2,15 Lung Primary cancer 973 Immune -> Immune Enriched 3.70 1.98e-2
NSCLC_38242124__IMC__175_C2,16 Lung Primary cancer 7,105 Immune -> Immune Enriched 5.63 1.98e-2
NSCLC_38242124__IMC__175_C2,2 Lung Primary cancer 1,267 Immune -> Immune Enriched 3.48 1.44e-2
NSCLC_38242124__IMC__175_C2,3 Lung Primary cancer 2,888 Tumor/Malignant -> Tumor/Malignant Enriched 4.52 1.06e-2
NSCLC_38242124__IMC__175_C2,4 Lung Primary cancer 3,614 Immune -> Immune Enriched 3.60 1.13e-2
NSCLC_38242124__IMC__175_C2,5 Lung Primary cancer 3,120 Tumor/Malignant -> Tumor/Malignant Enriched 4.19 1.58e-2
NSCLC_38242124__IMC__175_C2,6 Lung Primary cancer 4,083 Tumor/Malignant -> Tumor/Malignant Enriched 4.89 9.90e-3
NSCLC_38242124__IMC__175_C2,7 Lung Primary cancer 2,572 Tumor/Malignant -> Tumor/Malignant Enriched 4.86 1.32e-2
NSCLC_38242124__IMC__175_C2,8 Lung Primary cancer 2,498 Tumor/Malignant -> Tumor/Malignant Enriched 4.99 1.06e-2
NSCLC_38242124__IMC__175_C2,9 Lung Primary cancer 3,369 Tumor/Malignant -> Tumor/Malignant Enriched 5.15 1.06e-2
NSCLC_38242124__IMC__175_C3,1 Lung Primary cancer 2,395 Tumor/Malignant -> Tumor/Malignant Enriched 4.81 1.06e-2